JD Health International Inc.
JDHIF
Other OTC5.85
USD
- -
- -
ISIN
KYG5074A1004
CUSIP
G5074A100
Return %
Stock
S&P500
1Y
-6.70
18.21
3Y
-11.63
64.38
5Y
-53.57
72.43
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Dong Cao
- Full Time Employees
- 5,263
- Sector
- Healthcare
- Industry
- Medical - Healthcare Information Services
- Address
- Jingdong Headquarters Beijing BE People's Republic of China 101111
- IPO Date
- Dec 17, 2020
- Website
- ir.jdhealth.com
- Similar Companies
- Business
- JD Health International Inc engages in the provision of comprehensive online and offline healthcare products and services, including pharmaceutical and healthcare product retailing such as medicines, medical devices, nutritional supplements, and pet healthcare products; healthcare services including online consultation, chronic disease management, family doctor services, home care services, and medical escort; digital healthcare solutions for corporates and insurance companies; smart medical devices such as blood glucose meters, oxygen generators, and respiratory therapy devices; and online medical insurance payment and marketing services. The company operates primarily in China with expanding operations encompassing offline pharmacies and cross-border healthcare services connecting users with over 100 top global hospitals and specialists across countries including Switzerland, Japan, Thailand, and the United States. Founded in 2018 and headquartered in Beijing, JD Health has formed several strategic partnerships recently, including collaborations with multinational pharmaceutical companies such as Pfizer, GlaxoSmithKline, Sanofi, Bristol-Myers Squibb, Abbott, and Boehringer Ingelheim for expanded drug distribution, vaccination programs, chronic disease management platforms, and pet healthcare. It also signed a strategic cooperation agreement with INTCO Medical to develop high-end customized medical products and build a comprehensive medical protection ecosystem. In late 2024 and 2025, JD Health launched a global healthcare service platform facilitating direct referrals and remote consultations to international medical resources, and entered service cooperation agreements to enhance online sales and health management services. These latest moves signify JD Health's expansion from its core e-commerce-enabled pharmaceutical retail model into integrated digital and global healthcare services, leveraging technology and partnerships to enhance access to healthcare and innovative medical products. The company also continues to grow its offline pharmacy network and smart health device offerings to support an integrated healthcare ecosystem. This positions JD Health International Inc as a leading integrated healthcare service provider in China with increasing international outreach and a strong focus on innovation through partnerships and technology-driven medical service platforms.
JD Health International Inc. (JDHIF) Q2 2025 Earnings Call Transcript
JD Health International Inc. (JDHIF) Q4 2024 Earnings Call Transcript